NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/08/2024
Voltar para busca
Dado oficial do USPTO
INAGENE DIAGNOSTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
INAGENE DIAGNOSTICS
ST13
US500000088255707Classe
35, 41, 42, 44
Pedido
88255707
Registro
7470557
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
67
Atualização mais recente
13/08/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41, 42, 44
Data de depósito
09/01/2019
Data de registro
13/08/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/08/2024
Última transação
13/08/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Toronto, CA
Examinador
SABAGH, LAILA
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Inagene Diagnostics Inc.
Representantes
Matthew Warner-Blankenship Dentons Davis Brown
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Advertising the goods and services of others focused on the application of personal genetic information for pain managementmental health and other comorbid conditions; developing promotional campaigns focused on the application of personal genetic information for pain managementmental health and other comorbid conditionsmarketing servicesmarketing consultancy for businesses in the field of personal genetic information for pain managementmental health and other comorbid conditionsall the foregoing not including veterinary or plant applications
Classe 41
Providing online non-downloadable audio and video recordings containing information in the field of medical testing servicesgenetic testing and genetic screening over a global computer network
Classe 42
Genetic testing and genetic screening services for scientific research purposes; scientific research in the fields of genomics and genetics; scientific research in the application of personal genetic information with respect to medical or nutritional treatmentspharmaceuticals and clinical trials; providing genetic-based nutritional and pharmaceutical research information via the internet and via printed publications; providing clinical laboratory testing servicespharmacogenetic testsgene sequencing-based tests and genotyping based on the assessmentdevelopment and application of human genomic discoveries in the pharmaceuticalinformatics and human clinical diagnostic industriesall the foregoing not including veterinary or plant applications; medical research in the fields of genomics and genetics; providing genetic-based medical research information via the internet and via printed publications; medical research in the fields of pharmacogenomics and pharmacogenetics; providing temporary use of on-line non-downloadable software applications related to medical conditions addressed by medical testing servicesplatform as a service (PAAS) featuring computer software and mobile device applications for accessing information in the field of pain managementmental health and other comorbid conditions; providing genetic testing information for patients and healthcare professionals via an internet website portal; online services relating to medical testing servicesproviding genetic testing and genetic screening information for patients and healthcare professionals via an internet website portal
Classe 44
Medical diagnostic testing services and providing medical information in the form of personalized reports online in the field of genetic testing for medical purposes; providing clinical laboratory testing servicespersonalized medical tests based on the assessmentdevelopment and application of human genomic discoveries in the medical industry; online medical testing servicesgenetic testing and genetic screening; Medical information servicesproviding personalized information online in the field of genetic testing for medical purposes; medical information servicesreporting and providing feedback to patients and healthcare professionals on pharmacogenetic testing service results and relevance to medical and nutritional treatmentspersonal genetic information for pain managementmental health and other comorbid conditions and for understanding individual responses to medicationall the foregoing not including veterinary or plant applications; medical information servicesanalyzing pharmacogenetic testing service results and relevance to medical and nutritional treatmentsthe interaction between personal genetic information and pharmaceuticalsall the foregoing not including veterinary or plant applications; medical information servicespreparation of reports on pharmacogenetic testing service results and relevance to medical and nutritional treatmentsanalyzing individual pharmacogenetics and the interaction between personal genetic information and pharmaceuticalsall the foregoing not including veterinary or plant applications
Publicações
Histórico de despachos e eventos da marca no USPTO.
67 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
13/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/05/2024
PUBO
PUBLISHED FOR OPPOSITION
28/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/04/2024
NREV
NOTICE OF REVIVAL - E-MAILED
10/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2024
PGRR
PETITION GRANTED - RESPONSE RECEIVED
10/04/2024
APET
ASSIGNED TO PETITION STAFF
08/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
04/03/2024
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
22/01/2024
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
19/01/2024
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
19/01/2024
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
06/06/2023
GPRA
PRIORITY ACTION E-MAILED
06/06/2023
CPRA
PRIORITY ACTION WRITTEN
06/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/02/2023
ALIE
ASSIGNED TO LIE
14/02/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/02/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
06/08/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
06/08/2022
CNSI
SUSPENSION INQUIRY WRITTEN
06/08/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
24/06/2022
DOCK
ASSIGNED TO EXAMINER
07/03/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/12/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/12/2021
GNSL
LETTER OF SUSPENSION E-MAILED
06/12/2021
CNSL
SUSPENSION LETTER WRITTEN
06/12/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/06/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/12/2020
GNSL
LETTER OF SUSPENSION E-MAILED
03/12/2020
CNSL
SUSPENSION LETTER WRITTEN
03/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2020
ALIE
ASSIGNED TO LIE
29/11/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/11/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/05/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/05/2020
CNSI
SUSPENSION INQUIRY WRITTEN
01/05/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/11/2019
GNSL
LETTER OF SUSPENSION E-MAILED
01/11/2019
CNSL
SUSPENSION LETTER WRITTEN
01/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/10/2019
ALIE
ASSIGNED TO LIE
23/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/10/2019
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
24/09/2019
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
24/09/2019
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
24/09/2019
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
24/09/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
14/08/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/08/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
14/08/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/08/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/03/2019
GNRT
NON-FINAL ACTION E-MAILED
25/03/2019
CNRT
NON-FINAL ACTION WRITTEN
25/03/2019
DOCK
ASSIGNED TO EXAMINER
25/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/01/2019
NWAP
NEW APPLICATION ENTERED
12/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INAGENE DIAGNOSTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.